You are here

  • Home
  • Archive
  • Volume 69, Issue 8
  • RE: Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial

Article Text

Article menu
Download PDFPDF
PostScript
Letter
RE: Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial
  1. Michael Johnston1,
  2. Charlotte Cook1,2,
  3. Ryan Malcolm Buchanan1,2
  1. 1 Department of Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
  2. 2 Primary Care and Population Sciences, University of Southampton, Southampton, UK
  1. Correspondence to Dr Ryan Malcolm Buchanan, Primary Care and Population Sciences, University of Southampton, Southampton SO14 0DA, UK; ryan.buchanan{at}nhs.net

https://doi.org/10.1136/gutjnl-2019-319272

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the article by Ibrahim et al, which describes a randomised controlled trial (RCT) of early endoscopy with Hemospray within 2 hours of admission versus ‘early elective endoscopy’ at 12–24 hours for acute variceal bleeding (AVB).1

    We would like to make comments that relate to the internal and external validities of the study. The article indicates that participants consented and were randomised following admission with suspected AVB on the basis of probable underlying liver cirrhosis and fresh blood on nasogastric lavage. However, the article also described how 19 patients were excluded from the trial at endoscopy before randomisation. As the intervention was to undergo an immediate …

    View Full Text

    Footnotes

    • Contributors All three authors reviewed the manuscript and prepared the letter for submission. RB led the preparation of the final draft, which was seen by CC and MJ before submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; internally peer reviewed.